The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial

Inflammatory Cytokines in Heart Failure: Mediators and Markers

(2012) Lars Gullestad et al.   CARDIOLOGY

Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure

(2012) Erik Tandberg Askevold et al.   Circulation-Heart Failure

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

(2012) Kaspar Broch et al.   EUROPEAN JOURNAL OF HEART FAILURE

Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure

(2011) Michael R. Zile et al.   Circulation-Heart Failure

Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONA

(2011) Thor Ueland et al.   Circulation-Heart Failure

Mechanisms for the anti-inflammatory effects of statins

(2011) De-xiu Bu et al.   CURRENT OPINION IN LIPIDOLOGY

Recommendations of the European Association of Echocardiography How to use echo-Doppler in clinical trials: different modalities for different purposes

(2011) M. Galderisi et al.   European Journal of Echocardiography

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

(2010) Kenneth F Schulz et al.   BMC Medicine

The Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Cardiovascular Disease

(2010) Christos G. Mihos et al.   Cardiology in Review

Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study

(2010) Emma Ashton et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure

(2009) Michael J. Lipinski et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE